In Conversation

Quintiles first established its operations in India in 1997, which was a very early stage in clinical research. What have been the main changes undergone by…

Right after you started heading the India operations roughly 15 years ago, you had to oversee one the biggest mergers in the industry at that time.…

While we have seen many MNCs becoming increasingly interested in India, the story of Nycomed has been quite unique. Rather than starting off with marketing and…

Two weeks ago, Lupin announced its annual results, portraying 6 years of sustained growth and a net profit up by 27%. How pleased were you with…

Compared to 5 years ago, MNCs have increased their presence in India. Some even have become market leaders, particularly through acquisitions of domestic players. How is…

If we first take a step back and look at how Bharat Biotech was established, we see quite a remarkable story. It is rather exceptional to…

India has experienced tremendous growth in its chemical and pharmaceutical industries. Being active for many years in the industry now, how have you seen the market…

While your appointment as Managing Director was not a long time ago, you immediately faced the big task to oversee one of the most complicated corporate…

One trend we have seen taking place over the years is that, today, Indian machines are far better in quality and in par with international standards,…

PwC is undoubtedly renowned for its strong network of international expertise, but every market still has its own particularities… What is it, that your clients struggle…

Undeniably, the landscape for CROs has dramatically changed compared to when you started in the 1990s. The idea of having India as a clinical research destination…

There is no doubt that India has become a country of rising opportunities. Can you first elaborate how important India has become for the Group worldwide?…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here